BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32327261)

  • 21. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
    Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
    BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization.
    Patkowski W; Stankiewicz R; Grąt M; Krasnodębski M; Kornasiewicz O; Krawczyk M
    Transplant Proc; 2014 Oct; 46(8):2774-6. PubMed ID: 25380915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
    Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
    Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.
    Sapisochin G; de Lope CR; Gastaca M; de Urbina JO; López-Andujar R; Palacios F; Ramos E; Fabregat J; Castroagudín JF; Varo E; Pons JA; Parrilla P; González-Diéguez ML; Rodriguez M; Otero A; Vazquez MA; Zozaya G; Herrero JI; Antolin GS; Perez B; Ciria R; Rufian S; Fundora Y; Ferron JA; Guiberteau A; Blanco G; Varona MA; Barrera MA; Suarez MA; Santoyo J; Bruix J; Charco R
    Ann Surg; 2014 May; 259(5):944-52. PubMed ID: 24441817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed Hepatocellular Cholangiocarcinoma: A Review of Long-Term Outcomes Following Liver Transplantation.
    Machairas N; Stamopoulos P; Kostakis ID; Garoufalia Z; Paspala A; Tsaparas P; Sotiropoulos GC
    Transplant Proc; 2019 Mar; 51(2):437-439. PubMed ID: 30879560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes After Liver Transplantation With Incidental Cholangiocarcinoma.
    Safdar NZ; Hakeem AR; Faulkes R; James F; Mason L; Masson S; Powell J; Rowe I; Shetty S; Jones R; Spiers HVM; Halliday N; Baker J; Thorburn D; Prasad R; Parker R
    Transpl Int; 2022; 35():10802. PubMed ID: 36406780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?
    Sapisochin G; Rodríguez de Lope C; Gastaca M; Ortiz de Urbina J; Suarez MA; Santoyo J; Castroagudín JF; Varo E; López-Andujar R; Palacios F; Sanchez Antolín G; Perez B; Guiberteau A; Blanco G; González-Diéguez ML; Rodriguez M; Varona MA; Barrera MA; Fundora Y; Ferron JA; Ramos E; Fabregat J; Ciria R; Rufian S; Otero A; Vazquez MA; Pons JA; Parrilla P; Zozaya G; Herrero JI; Charco R; Bruix J
    Am J Transplant; 2014 Mar; 14(3):660-7. PubMed ID: 24410861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.
    Shimoda M; Farmer DG; Colquhoun SD; Rosove M; Ghobrial RM; Yersiz H; Chen P; Busuttil RW
    Liver Transpl; 2001 Dec; 7(12):1023-33. PubMed ID: 11753904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
    Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma.
    Fu Y; Yang W; Wu W; Yan K; Xing BC; Chen MH
    J Vasc Interv Radiol; 2012 May; 23(5):642-9. PubMed ID: 22525022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidental Intra-Hepatic Cholangiocarcinoma and Hepatocholangiocarcinoma in Liver Transplantation: A Single-Center Experience.
    Serra V; Tarantino G; Guidetti C; Aldrovandi S; Cuoghi M; Olivieri T; Assirati G; De Ruvo N; Magistri P; Ballarin R; Di Benedetto F
    Transplant Proc; 2016 Mar; 48(2):366-9. PubMed ID: 27109957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of liver transplantation for cholangiocarcinoma.
    Goldaracena N; Gorgen A; Sapisochin G
    Liver Transpl; 2018 Feb; 24(2):294-303. PubMed ID: 29024405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results.
    Friman S; Foss A; Isoniemi H; Olausson M; Höckerstedt K; Yamamoto S; Karlsen TH; Rizell M; Ericzon BG
    Scand J Gastroenterol; 2011 Mar; 46(3):370-5. PubMed ID: 21073376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver Transplantation for Cholangiocarcinoma: Insights into the Prognosis and the Evolving Indications.
    Panayotova GG; Paterno F; Guarrera JV; Lunsford KE
    Curr Oncol Rep; 2020 Apr; 22(5):49. PubMed ID: 32297105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    World J Surg; 2008 Dec; 32(12):2675-80. PubMed ID: 18843437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.
    Panjala C; Nguyen JH; Al-Hajjaj AN; Rosser BA; Nakhleh RE; Bridges MD; Ko SJ; Buskirk SJ; Kim GP; Harnois DM
    Liver Transpl; 2012 May; 18(5):594-601. PubMed ID: 22140024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution.
    Kim DH; Choi DW; Choi SH; Heo JS; Kow AW
    Surgery; 2015 Apr; 157(4):666-75. PubMed ID: 25682172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidental intrahepatic cholangiocarcinoma in patients undergoing liver transplantation: A multi-center study in Japan.
    Hara T; Eguchi S; Yoshizumi T; Akamatsu N; Kaido T; Hamada T; Takamura H; Shimamura T; Umeda Y; Shinoda M; Ogura Y; Fukumoto T; Kasahara M; Hibi T; Umeshita K; Furukawa H; Ohdan H
    J Hepatobiliary Pancreat Sci; 2021 Apr; 28(4):346-352. PubMed ID: 33464720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.